chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I am the patient. I do not have the lot number. I received it and was fine initially. I felt a little euphoric in my head. Light headed I guess you could say. After about 10 mins of that I felt a little sensation in my legs. It did not last long. I thought maybe just nerves. After about 15-20 minutes I walked outside to maybe leave. I started feeling a little Soreness (none painful or severe) in my throat. I looked in the mirror and saw two small red patches in the very back of the throat. I looked at my phone to text who followed me and looked back in the mirror to see they had no connected that quickly. With in 10 seconds. I walked back in and they gave me 50 mg of Benadryl. I could still breath and had a good air way. My throat a little tight. I remember feeling this euphoric feeling in my head. After about 15 mins of the Benadryl I was getting bettter. I hung around for a little while and left. I know it was a allergy but honestly considered going back for the second dose of that is how it could be handled again. I felt some small dull none painful sharp pains if that makes sense in my sides and stomach that didn?t not linger. Over all it wasn?t so bad. This is my first day however and if more arises I?ll be sure to let you know. I did experience a very sore arm tonight. To even lift it hurt. Worse than other vaccines. I have never had any reactions to other vaccines.
I'm not feeling very good; I don't know if I am trying to come down with a cold; my stomach is bothering me as well; she is not feeling good since yesterday; Missed dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 78 year-old female patient received bnt162b2 (BNT162B2), administration date 08Apr2021 (Lot number: ER8734) at the age of 78 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Stage 4 Cancer" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PRODUCT DOSE OMISSION ISSUE (non-serious) with onset 29Apr2021, outcome "not recovered", described as "Missed dose"; MALAISE (non-serious), outcome "unknown", described as "I'm not feeling very good"; NASOPHARYNGITIS (non-serious), outcome "unknown", described as "I don't know if I am trying to come down with a cold"; ABDOMINAL DISCOMFORT (non-serious), outcome "unknown", described as "my stomach is bothering me as well"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "she is not feeling good since yesterday".  Additional information- She had stage 4 cancer.  Caller clarified that she was diagnosed with the Stage 4 Cancer prior to receiving the covid vaccine. She also clarifies that the second dose was originally scheduled on 29APR2021, but she missed that, and so she decided to call the Medical Center where she got her first dose and they rescheduled her for today, 11MAY2021, but she was missing today dose. Caller asks is this the last time she could come in for a second dose or she had to go somewhere else.  No follow-up attempts are possible. No further information is expected.
Large raised arm swelling 8 days post injection over injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE SWELLING (Large raised arm swelling 8 days post injection over injection site) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 011320A) for COVID-19 vaccination.     The patient's past medical history included Anal dilation procedure. Concurrent medical conditions included Ulcerative colitis and Drug allergy (Cipro, morphine and ibuprofen products). Concomitant products included LORATADINE (ALLERCLEAR) for Allergy, RAMIPRIL for Blood pressure management.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021 at 8:00 AM, the patient experienced VACCINATION SITE SWELLING (Large raised arm swelling 8 days post injection over injection site). At the time of the report, VACCINATION SITE SWELLING (Large raised arm swelling 8 days post injection over injection site) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered VACCINATION SITE SWELLING (Large raised arm swelling 8 days post injection over injection site) to be possibly related.    This case was linked to MOD-2021-011942, MOD-2021-011942 (Patient Link).
01/22/22 transferred to IPR for "intense inpatient rehabilitation". PMHx of "ESRD on PD, HTN, DM1, COPD, CHB w/ PPM and anemia of chronic disease"
5/7/07-Patient complained of pruritic raised rash on trunk, back, legs and arms. Better on 5/8/07. 5/9/07 -hives again on face and hands now. Symptoms were treated with Benadryl, with complete resolution on 5/11/07.
Transferred to 2nd Hospital, from 1st hospital on 9/2/2011 with 3 day history of double vision, facial weakness, and paresthesias in right hand and both feet.  She was admittedand continued to have progression of symptoms with difficulty walking and dysphagia nd continuation of initial symptoms.  She did not develop resiratory problems. At both hospitals studies were negative, but at 2nd she was treated with plasmapheresis and her symptoms improved. She was discharged 9/10/2011.  She received PT here and at this time she has made remarkable progress.  PT expects to discontinue therepy next week.  She is able to run on a treadmill and lift weights, though her strength might not be completely back tobaseline.
Received the Booster on 12/23 injection sight was sore as expected however, work up 12/26 at 6am and injection sight has become swollen, very red, and hot to the touch.  it is now itching.  I've been applying ice and antibiotic cream to the injection sight.  Was taking Benadryl however, caused sinus headaches so, am taking Tylenol instead.   Still have headaches, aches all over, chills come and go, fever, doest go over 99, fatigue, and a cough.
Large red, itchy rash spreading from injection site down and across arm starting 12 days after 1st vaccine dose, continues to itch 2 days later, has gotten larger and has raised edges.
fever, temp. blindness lasted 1 week left eye 2 weeks sight came back on its own just stayed home.
"10 minutes after vaccine, pt complained of metallic taste in mouth, tingling tongue. EMT attended, Vitals stable throughout. Voice hoarse and getting worse, dry throat. Ambulance called. Alert and oriented. Hx of meds allergy denied anaphylactic reaction."  "Taken to Hospital Supervisors Report  *pt has not registered for 2nd Dose
Extreme chills and vomiting  episode lasting approximately 5 hours and weak for about a day.
Breakthrough case admission after 4 vaccines Pfizer 2/9/21 Lot# EL9267;  3/3/21 Pfizer Lot# EN6202;  Pfizer 10/19/21 Lot# FF8841;  Pfizer 6/13/22 Lot# FP7135
nurse stated that wasn't sure how much of the dose enter the armnot sure if sufficient dose went inside the arm; A little bit of soreness; This spontaneous case was reported by a patient and describes the occurrence of ACCIDENTAL UNDERDOSE (nurse stated that wasn't sure how much of the dose enter the armnot sure if sufficient dose went inside the arm) and VACCINATION SITE PAIN (A little bit of soreness) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included VITAMIN D NOS for an unknown indication.    On 22-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-May-2021, the patient experienced ACCIDENTAL UNDERDOSE (nurse stated that wasn't sure how much of the dose enter the armnot sure if sufficient dose went inside the arm) and VACCINATION SITE PAIN (A little bit of soreness). On 22-May-2021, ACCIDENTAL UNDERDOSE (nurse stated that wasn't sure how much of the dose enter the armnot sure if sufficient dose went inside the arm) had resolved. At the time of the report, VACCINATION SITE PAIN (A little bit of soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications includes medication for blood pressure.
Patient had a vasovagal episode at about 11 am after receiving both vaccinations. He fell against the hinge of the hall door as patient and mom were leaving. Patient sustained a scalp laceration. Did not lose consciousness, and did not feel dizzy afterwards, denied any headaches. After incident mom reported that something similar had occurred when child received immunizations. Patient and mom stayed and patient observed until 11:30. Patient walked out, looking tired.
Information has been received from an 83 year old female who in approximately 2008 was vaccinated with ZOSTAVAX vaccine (Merck). Concomitant therapy included COREG. On 15-MAR-2009 the patient experienced fever and headache. On 18-MAR-2009 "the patient started breaking out on her neck and 2 days later she was breaking out on her scalp". The patient's doctor diagnosed this as shingles, additionally the patient stated that her doctor had prescribed LORTAB for the headache "but it made the headache worse". The patient was recovering and she sought unspecified medical attention. Follow up has been received from a physician who reported that the patient (age reported as 70 years old) who was vaccinated with ZOSTAVAX vaccine (Merck) with in the last year and developed shingles. The physician reported, the patient still had an active case of shingles. Additional information has been requested.
soreness at ankle, hip.; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (soreness at ankle, hip.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (soreness at ankle, hip.). At the time of the report, ARTHRALGIA (soreness at ankle, hip.) outcome was unknown.            Patient experienced soreness at ankle and hip after the second dose. Concomitant product use was not provided by the reporter. Treatment information was not provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Tiredness, extreme emotion - tears out of proportion to stimulus, inability to focus following one of sleeplessness
She missed her second dose; she had no taste or smell and tested positive for COVID-19; she had no taste or smell and tested positive for COVID-19; This is a spontaneous report from a contactable consumer(patient) via medical information team. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported), via an unspecified route of administration on 10Jan2021 as single dose for covid-19 immunization. Patient medical history and concomitant medications were not reported. Patient stated she received the first dose of the Pfizer COVID vaccine on 10Jan2021 and her second dose was scheduled on 31Jan2021. On 28Jan2021 when she woke up she had no taste or smell and tested positive for COVID-19. She missed her second dose on 31Jan2021 and wanted to know when can she take her second dose. Outcome of the events was unknown.  Information about batch/lot number has been requested.
Hives all over body, very itchy. Saw the hives on day 1, still has the hives 12 days later.
Myalgia INJECTION SITE PAIN, MILD LASTING 3 DAYS Narrative:
Fatigue on 03/04/2021 - went to bed for the night at 10:00 pm MST; Fatigue on 03/05/2021 - went to bed for 3 hour nap beginning at 11:30 am MST
pt recv vax 20OCT98 & w/in 2hr pt devel jaw soreness, mild facial swelling, sinus congestion, mild h/a, fatigue, weakness & nausea;
INTUSSUSCEPTION 03/22/07-ER report and DC summary received for 2/26/07 Ileocolic intussusception. Successfully reduced into the distal ileum with air contrast enema. Status post dehydration, resolved. History of persistent vomiting since 2/24/07. Diarrhea last week for 3 days with no bloody stools. No stools since 2/23/07- PE WNL except for abdomen slight distended and increased bowel sounds. No palpable mass. 03/23/07-records received for DOS 2/25/07-DX:gastroenteritis, dehydration.
This case was reported by a pharmacist and described the occurrence of diarrhea in a 54-year-old male subject who was vaccinated with FLULAVAL (GlaxoSmithKline). On 10 October 2013 the subject received a dose of FLULAVAL (unknown details). On 10 October 2013, within hours of vaccination with FLULAVAL, the subject experienced diarrhea. The pharmacist reported that the subject "received a FLULAVAL vaccination at the same time as his girlfriend. They went out to dinner afterwards and when they got home they started experiencing diarrhea." See case A1047930A for details on the female subject. On 10 October 2013, the event was resolved. The pharmacist reported that "after one bout of diarrhea his symptoms resolved." The pharmacist reported other cases with FLULAVAL. See A1047930A and A1046504A for details on the other cases.
itching of the right hand; rash on right hand; red and painful rash from neck to abdomen including arms; on and off headaches; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching of the right hand), RASH (rash on right hand), RASH ERYTHEMATOUS (red and painful rash from neck to abdomen including arms) and HEADACHE (on and off headaches) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PARACETAMOL (TYLENOL), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) and HYDROCORTISONE.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On an unknown date, the patient experienced PRURITUS (itching of the right hand), RASH (rash on right hand), RASH ERYTHEMATOUS (red and painful rash from neck to abdomen including arms) and HEADACHE (on and off headaches). At the time of the report, PRURITUS (itching of the right hand), RASH (rash on right hand), RASH ERYTHEMATOUS (red and painful rash from neck to abdomen including arms) and HEADACHE (on and off headaches) outcome was unknown.            This case was linked to MOD-2021-044888, MOD-2021-044888 (Patient Link).
Began running fever at 2pm 101.8 on 11/15/10 at daycare. Taken to MD - given MOTRIN then vomited. Temp at Dr. office 102.? (almost 103 degrees) gave acetaminophen suppository - Began with seizure at MD office.
Pt developed facial erythema, edema and mild wheezing about 5-20 minutes after injection.
Patient started feeling tingly and numbness on right arm and leg. She also expressed some visual aura and weakness. Patient stayed seated and was monitored and given water. She stayed until 2pm when her mother came to pick her up. She said she was feeling a little better. Patient was advised to follow up with primary care provider.
woozy feeling; felt like her head was disconnected from her body; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (woozy feeling) and FEELING ABNORMAL (felt like her head was disconnected from her body) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced DIZZINESS (woozy feeling) and FEELING ABNORMAL (felt like her head was disconnected from her body). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form; IPRATROPIUM BROMIDE, SALBUTAMOL SULFATE (FARBIVENT) at a dose of 1 dosage form; BECLOMETASONE DIPROPIONATE (QVAR) at a dose of 1 dosage form and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at a dose of 1 dosage form. On 25-Jan-2021, DIZZINESS (woozy feeling) and FEELING ABNORMAL (felt like her head was disconnected from her body) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.   This case was linked to MOD-2021-027034 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: - No new information was provided.
1st Shot:  March 2, 2006, Thursday Dizzy, nausea, headaches, body aches.  Took pain reliever medicine for aches. (Stayed home day after shot to rest.) Called doctor and he advised that my immune system may probably be low and to ride it out.  If I didn't get better, to come in.  Symptoms went away w/in 3 1/2 days. 2nd Shot:  April 27, 2006, Thursday Slight dizziness and nausea.  Took pain reliever medicine for aches. Friday - Went to work.  Had nausea, headaches, body aches.   At 6pm started shivering for 1 1/2 hours.  2 finger tips tingled. Took hot shower.  Noticed cuticles turning purple.  After chills, had a slight fever.  Had a slight episode of chills during sleep time. Saturday - Woke up with severe body aches, dizziness and nausea.  Took pain reliever and dragged into work. Sunday - Wore off...Symptoms were not severe.
At 7:15 patient started getting a headache took 2 Aleve and laid down for a nap. At 9pm she had a fever of 103.8 and the fever lasted an hour. She them had extreme headache. excurtiating pain like a charley horse in her legs and her hands and feet were tingling. There was no site reaction.
Lightheaded, confused, forgetful, tired, achy 4/24-current  Migraine 4/25-4/26 Low fever 4/25-4/27
Patient had no reaction on day of vaccination - delayed onset. Woke up the following day and noticed pain, redness and swelling near the injection site.
Approximately 15 minutes of sitting following vaccine administration, patient stood, walked several steps and fainted. Vitals were stable. No LOC.
Initial case retrieved from the scientific literature on 25 April 2011. It pertains to 1 of 4 patients who experienced adverse events following exposure to a military service member who had recently received the ACAM2000 vaccine. The other 3 patients are captured in case numbers 2010-04089, 2010-04090, 2011-02467; the case for the military service member is captured in 2011-02465. This case involves tertiary spread of vaccinia due to inadvertent inoculation. This case was coded as secondary transmission despite the reported term of tertiary transmission due to coding limitations. Abstract: During February and March 2010, the State Department of Health investigated secondary and tertiary vaccinia contact transmission from a military vaccinee to 4 close contacts. Identification of these cases underscores the need for strict adherence to postvaccination infection control guidance to avoid transmission of the live virus. On 23 February 2010, a military service member received ACAM2000 in preparation for deployment. On 27 February 2010 he wrestled 2 persons in a semi-professional wrestling match, during which the dressing covering the vaccination site was detached. On 5 March 2010, one of the exposed wrestlers participated in another wresting match with a 25-year-old male whose information is captured in this case. The patient had a history of recent mild eczema involving his hands; in addition, he was a roommate of the vaccinee. On 7 March 2010, 2 days after his wresting match with one of the exposed wrestlers from the 27 February 2010 match, he developed lesions, described as pruritic papules, on the chest, trunk, and arm. On 10 March 2010 he sought treatment for the lesions. His physician thought the lesions appeared to be molluscum contagiosum, however given the patient's history he consulted an infectious disease physician who observed lesions compatible with vaccinia virus (VACV). At his public health evaluation on 12 March 2010, he was noted to have grouping of vesicular lesions with central umbilication on mildly erythematous bases on his trunk, with a solitary lesion near his left areola and on the volar aspect of his right forearm. VACV was clinically diagnosed. The patient was followed until he had complete lesion resolution, approximately 7 weeks. A tissue sample was obtained by unroofing a vesicle, collecting the tissue, performing slide touch preps of the unearthed base of the vesicle, and obtaining viral swabs by using pox collection kits which had been distributed through the state department of health. The specimen was treated by real-time PCR, and preliminary results indicated VAVC. Test results were subsequently confirmed, and a complete hemagglutinin gene was sequenced by the CDC (Centers for Disease Control and Prevention) and was identical to that of ACAM2000. Documents held by sender: None.
Pt got lightheaded and felt like his heart was racing about 5 minutes after the vaccine. The effects went away pretty quickly. Pt sat in lobby about 30 minutes and had no symptoms at time of departure. Checked in with pt at the end of the day and he was feeling fine and had no symptoms.
Pt states nausea, aches, general malaise, dry mouth since the day after her shot and continuing as of today 04/09/21
With in one hour patient experienced severe Vomiting and Diarrhea.  She had called her Doctors office.  She saw a PA which told her to drink more water.  She experienced Uncontrollable Diarrhea For 18 days.  She was sent to Hospital by ambulance on Monday March 15, 2021.  She was was treated with an IV and sent home discharged with Weakness.   She continued to have Uncontrollable Diarrhea to were she was wearing Diapers.  She fell from Weakness on March 16, 2021 to the point where she laid on the floor for an hour and half before she could drag herself up.  She went to Hospital on March 18, 2021.  Her blood pressure dropped and was admitted to ICU on the March 18th.  She started suffering from a Heart attack and was taken back to have a stent put in her wrist to help with possible heart blockage.  She went into cardiac  arrest and passed away.
Patient was sore. Mom applied heating pad at night. Patient woke up with a local reaction. Site was tender, red, warm and had blister-like bumps just below site.
Mom states child started with fever on 7-27-10. By 7-30-10 child had a spotted red raised rash all over body. Had trouble sleeping at night. Fever was low grade for a couple of days. APN said child had an allergic reaction to shots.
covid; covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "covid".  The lot number for bnt162b2 was not provided and will be requested during follow up.